Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00333502
Status:
COMPLETED
Last Update Posted:
2020-05-28
First Post:
2006-06-01
Brief Title:
Study of CRLX101 NLG207 in the Treatment of Advanced Solid Tumors
Sponsor:
NewLink Genetics Corporation
Organization:
Lumos Pharma
Organization Data
Organization:
Lumos Pharma
Class:
INDUSTRY
Study ID:
CRLX-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NewLink Genetics Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None